Introduction

 

The first sign that you could have cancer may come from a routine screening test (such as a mammogram or colonoscopy), a health exam to identify the cause of a symptom or problem, or a procedure to treat another condition. 

If your doctor believes that you could have cancer, he or she will order several different kinds of tests to confirm that you have cancer and not another disease or condition, identify the kind of cancer you have, and find out how far the cancer has spread. After using these tests to diagnose, or identify, your cancer, your doctor might use more tests to find the best treatments for your disease, track your treatment progress, and monitor your overall health.

Explore the links in the column to the right to learn about cancer screening and diagnosis, the various tests you may need, and important questions to ask about your diagnosis and testing.

Latest Cancer News
ACS Guidelines for Breast Screening with MRI May Be Excluding Some High-risk Women

January 6, 2009 — The American Cancer Society (ACS) has developed a set of guidelines to recommend which high-risk women need to undergo screening with breast magnetic resonance imaging (MRI); however, these guidelines may unwittingly exclude some women who are at a high risk of carrying the BRCA mutation yet still don’t meet the limitations set by the ACS. The results of this study were published in the journal Cancer.

Colonoscopy Fails to Identify Many Colorectal Cancers

January 6, 2009 — Colonoscopy, a standard screening method for colorectal cancer, misses the majority of cancers on the right side of the colon and about one-third of cancers on the left side of the colon, according to the results of a study published in the Annals of Internal Medicine. The researchers estimated that the screening method may reduce colorectal cancer mortality by 60-70%, rather than 90% as previously estimated.

High-dose Faslodex® Improves Time to Progression Compared with Arimidex® as Initial Therapy in Advanced Breast Cancer

January 6, 2009 — Researchers affiliated with an international trial have reported that high-dose Faslodex® (fulvestrant) significantly improves time to cancer progression compared with Arimidex® (anastrozole) as initial therapy for hormone-positive, advanced breast cancer. These results were recently presented at the 2008 annual San Antonio Breast Cancer Symposium December 10-14, 2008.

Select news items provided by Reuters Health